To further approve that ZDHHC18 is a mesenchymal GSCs marker and ZDHHC23 is a marker for proneural GSCs, we also used SOX2 and YKL40 to identify and verify the ZDHHC18-positive and ZDHHC23-positive GBM cells, respectively. Here, ZDHHC23 is linked to glioblastoma.